The clinical implications of recent studies on the structure and function of the retinal microvasculature in diabetes

Diabetologia

Volumn 58, Issue 5, 2015, Pages 871-885

  Cheung, Carol Yimlui ^a,b,c   Ikram, M Kamran ^a,b,c   Klein, Ronald ^d   Wong, Tien Yin ^a,b,c  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Diabetes; Diabetic complications; Retina; Retinal microvasculature; Retinal vascular changes; Retinal vascular function; Retinal vascular structure; Retinal vessels; Review

Indexed keywords

DIABETES MELLITUS; DIABETIC RETINOPATHY; HUMAN; HYPERGLYCEMIA; MICROVASCULATURE; PATHOLOGY; PATHOPHYSIOLOGY; RETINA; RETINA BLOOD VESSEL;

DIABETES MELLITUS; DIABETIC RETINOPATHY; HUMANS; HYPERGLYCEMIA; MICROVESSELS; RETINA; RETINAL VESSELS;

EID: 84939953650     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3511-1     Document Type: Review

References (117)

1. International Diabetes Federation (2014) IDF diabetes atlas, 6th edn. IDF, Brussels
2. Terry T, Raravikar K, Chokrungvaranon N, Reaven PD (2012) Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT. Curr Cardiol Rep 14:79–88
3. Sarwar N, Gao P, Seshasai SR et al (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375:2215–2222
4. Nathan DM (1993) Long-term complications of diabetes mellitus. N Engl J Med 328:1676–1685
5. Chew EY, Ambrosius WT, Davis MD et al (2010) Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 363:233–244
6. Giorgino F, Leonardini A, Laviola L (2013) Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials. Ann NY Acad Sci 1281:36–50
7. Brown A, Reynolds LR, Bruemmer D (2010) Intensive glycemic control and cardiovascular disease: an update. Nat Rev Cardiol 7:369–375
8. Cheung N, Mitchell P, Wong TY (2010) Diabetic retinopathy. Lancet 376:124–136
9. Cheung CY, Ikram MK, Sabanayagam C, Wong TY (2012) Retinal microvasculature as a model to study the manifestations of hypertension. Hypertension 60:1094–1103
10. Haritoglou C, Kernt M, Neubauer A et al (2014) Microaneurysm formation rate as a predictive marker for progression to clinically significant macular edema in nonproliferative diabetic retinopathy. Retina 34:157–164
11. Ribeiro ML, Nunes SG, Cunha-Vaz JG (2013) Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy. Diabetes Care 36:1254–1259
12. Orasanu G, Plutzky J (2009) The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 53:S35–S42
13. Wiernsperger NF (2001) In defense of microvascular constriction in diabetes. Clin Hemorheol Microcirc 25:55–62
14. Sheetz MJ, King GL (2002) Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA 288:2579–2588
15. Anonymous (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329:977–986
16. Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615–1625
17. Ejaz S, Chekarova I, Ejaz A, Sohail A, Lim CW (2008) Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy. Diabetes Obes Metab 10:53–63
18. Yu JY, Lyons TJ (2013) Modified lipoproteins in diabetic retinopathy: a local action in the retina. J Clin Exp Ophthalmol 4:314
19. Wolf G, Chen S, Ziyadeh FN (2005) From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 54:1626–1634
20. Murata T, Nagai R, Ishibashi T, Inomuta H, Ikeda K, Horiuchi S (1997) The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas. Diabetologia 40:764–769
21. Klein R, Klein BE, Moss SE et al (2003) Retinal vascular abnormalities in persons with type 1 diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVIII. Ophthalmology 110:2118–2125
22. Klein R, Klein BE, Moss SE et al (2004) The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol 122:76–83
23. Hubbard LD, Brothers RJ, King WN et al (1999) Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 106:2269–2280
24. Wong TY, Knudtson MD, Klein R, Klein BE, Meuer SM, Hubbard LD (2004) Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology 111:1183–1190
25. Murray CD (1926) The physiological principle of minimum work: I. The vascular system and the cost of blood volume. Proc Natl Acad Sci U S A 12:207–214
26. Tooke JE (1995) Microvascular function in human diabetes. A physiological perspective. Diabetes 44:721–726
27. Hughes AD, Wong TY, Witt N et al (2009) Determinants of retinal microvascular architecture in normal subjects. Microcirculation 16:159–166
28. Thomas GN, Ong SY, Tham YC et al (2014) Measurement of macular fractal dimension using a computer-assisted program. Invest Ophthalmol Vis Sci 55:2237–2243
29. Patton N, Pattie A, Macgillivray T et al (2007) The association between retinal vascular network geometry and cognitive ability in an elderly population. Invest Ophthalmol Vis Sci 48:1995–2000
30. Doubal FN, MacGillivray TJ, Patton N, Dhillon B, Dennis MS, Wardlaw JM (2010) Fractal analysis of retinal vessels suggests that a distinct vasculopathy causes lacunar stroke. Neurology 74:1102–1107
31. Cheung CY, Tay WT, Mitchell P et al (2011) Quantitative and qualitative retinal microvascular characteristics and blood pressure. J Hypertens 29:1380–1391
32. Cheung CY, Hsu W, Lee ML et al (2010) A new method to measure peripheral retinal vascular caliber over an extended area. Microcirculation 17:495–503
33. Kohner EM, Stratton IM, Aldington SJ, Turner RC, Matthews DR (1999) Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group. Diabetologia 42:1107–1112
34. Hellstedt T, Immonen I (1996) Disappearance and formation rates of microaneurysms in early diabetic retinopathy. Br J Ophthalmol 80:135–139
35. Nunes S, Pires I, Rosa A, Duarte L, Bernardes R, Cunha-Vaz J (2009) Microaneurysm turnover is a biomarker for diabetic retinopathy progression to clinically significant macular edema: findings for type 2 diabetics with nonproliferative retinopathy. Ophthalmologica 223:292–297
36. Leicht SF, Kernt M, Neubauer A et al (2014) Microaneurysm turnover in diabetic retinopathy assessed by automated RetmarkerDR image analysis—potential role as biomarker of response to ranibizumab treatment. Ophthalmologica 231:198–203
37. Wong TY, Klein R, Sharrett AR et al (2002) Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA 287:2528–2533
38. Wong TY, Shankar A, Klein R, Klein BE, Hubbard LD (2005) Retinal arteriolar narrowing, hypertension, and subsequent risk of diabetes mellitus. Arch Intern Med 165:1060–1065
39. Ikram MK, Janssen JA, Roos AM et al (2006) Retinal vessel diameters and risk of impaired fasting glucose or diabetes: the Rotterdam study. Diabetes 55:506–510
40. Kifley A, Wang JJ, Cugati S, Wong TY, Mitchell P (2007) Retinal vascular caliber, diabetes, and retinopathy. Am J Ophthalmol 143:1024–1026
41. Tikellis G, Wang JJ, Tapp R et al (2007) The relationship of retinal vascular calibre to diabetes and retinopathy: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Diabetologia 50:2263–2271
42. Nguyen TT, Wang JJ, Islam FM et al (2008) Retinal arteriolar narrowing predicts incidence of diabetes: the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study. Diabetes 57:536–539
43. Nguyen TT, Wang JJ, Sharrett AR et al (2008) Relationship of retinal vascular caliber with diabetes and retinopathy: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 31:544–549
44. Islam FM, Nguyen TT, Wang JJ et al (2009) Quantitative retinal vascular calibre changes in diabetes and retinopathy: the Singapore Malay Eye Study. Eye (Lond) 23:1719–1724
45. Tsai AS, Wong TY, Lavanya R et al (2011) Differential association of retinal arteriolar and venular caliber with diabetes and retinopathy. Diabetes Res Clin Pract 94:291–298
46. Cheung CY, Lamoureux E, Ikram MK et al (2012) Retinal vascular geometry in Asian persons with diabetes and retinopathy. J Diabetes Sci Technol 6:595–605
47. Sasongko MB, Wong TY, Nguyen TT, Cheung CY, Shaw JE, Wang JJ (2011) Retinal vascular tortuosity in persons with diabetes and diabetic retinopathy. Diabetologia 54:2409–2416
48. Sasongko MB, Wang JJ, Donaghue KC et al (2010) Alterations in retinal microvascular geometry in young type 1 diabetes. Diabetes Care 33:1331–1336
49. Sun C, Wang JJ, Mackey DA, Wong TY (2009) Retinal vascular caliber: systemic, environmental, and genetic associations. Surv Ophthalmol 54:74–95
50. Roy MS, Klein R, Janal MN (2012) Relationship of retinal vessel caliber to cardiovascular disease and mortality in African Americans with type 1 diabetes mellitus. Arch Ophthalmol 130:561–567
51. Cheung N, Rogers SL, Donaghue KC, Jenkins AJ, Tikellis G, Wong TY (2008) Retinal arteriolar dilation predicts retinopathy in adolescents with type 1 diabetes. Diabetes Care 31:1842–1846
52. Broe R, Rasmussen ML, Frydkjaer-Olsen U et al (2014) Retinal vessel calibers predict long-term microvascular complications in type 1 diabetes: the Danish Cohort of Pediatric Diabetes 1987 (DCPD1987). Diabetes 63:3906–3914
53. Broe R, Rasmussen ML, Frydkjaer-Olsen U et al (2014) Retinal vascular fractals predict long-term microvascular complications in type 1 diabetes mellitus: the Danish Cohort of Pediatric Diabetes 1987 (DCPD1987). Diabetologia 57:2215–2221
54. Klein R, Klein BE, Moss SE, Wong TY (2007) Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 114:1884–1892
55. Rogers SL, Tikellis G, Cheung N et al (2008) Retinal arteriolar caliber predicts incident retinopathy: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Diabetes Care 31:761–763
56. Ikram MK, Cheung CY, Lorenzi M, Klein R, Jones TL, Wong TY (2013) Retinal vascular caliber as a biomarker for diabetes microvascular complications. Diabetes Care 36:750–759
57. Falck A, Laatikainen L (1995) Retinal vasodilation and hyperglycaemia in diabetic children and adolescents. Acta Ophthalmol Scand 73:119–124
58. Antonetti DA, Klein R, Gardner TW (2012) Diabetic retinopathy. N Engl J Med 366:1227–1239
59. Simo R, Hernandez C (2012) Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications. Br J Ophthalmol 96:1285–1290
60. Klein R, Knudtson MD, Klein BE et al (2010) The relationship of retinal vessel diameter to changes in diabetic nephropathy structural variables in patients with type 1 diabetes. Diabetologia 53:1638–1646
61. Wong TY, Shankar A, Klein R, Klein BE (2004) Retinal vessel diameters and the incidence of gross proteinuria and renal insufficiency in people with type 1 diabetes. Diabetes 53:179–184
62. Sabanayagam C, Tai ES, Lee J, Lim SC, Wong TY (2010) Retinal vessel caliber and peripheral neuropathy in diabetic participants. Microcirculation 17:297–302
63. Ding J, Cheung CY, Ikram MK et al (2012) Early retinal arteriolar changes and peripheral neuropathy in diabetes. Diabetes Care 35:1098–1104
64. Grauslund J, Hodgson L, Kawasaki R, Green A, Sjolie AK, Wong TY (2009) Retinal vessel calibre and micro- and macrovascular complications in type 1 diabetes. Diabetologia 52:2213–2217
65. van Hecke MV, Dekker JM, Stehouwer CD et al (2005) Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study. Diabetes Care 28:1383–1389
66. Cheung N, Wang JJ, Klein R, Couper DJ, Sharrett AR, Wong TY (2007) Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Diabetes Care 30:1742–1746
67. Cheung N, Wong TY (2008) Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res 27:161–176
68. Klein BE, Klein R, McBride PE et al (2004) Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med 164:1917–1924
69. Miller RG, Prince CT, Klein R, Orchard TJ (2009) Retinal vessel diameter and the incidence of coronary artery disease in type 1 diabetes. Am J Ophthalmol 147:653–660
70. Grauslund J, Green A, Kawasaki R, Hodgson L, Sjolie AK, Wong TY (2010) Retinal vascular fractals and microvascular and macrovascular complications in type 1 diabetes. Ophthalmology 117:1400–1405
71. Lim M, Sasongko MB, Ikram MK et al (2013) Systemic associations of dynamic retinal vessel analysis: a review of current literature. Microcirculation 20:257–268
72. Nguyen TT, Kawasaki R, Wang JJ et al (2009) Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy. Diabetes Care 32:2075–2080
73. Mandecka A, Dawczynski J, Blum M et al (2007) Influence of flickering light on the retinal vessels in diabetic patients. Diabetes Care 30:3048–3052
74. Garhofer G, Zawinka C, Resch H, Kothy P, Schmetterer L, Dorner GT (2004) Reduced response of retinal vessel diameters to flicker stimulation in patients with diabetes. Br J Ophthalmol 88:887–891
75. Lecleire-Collet A, Audo I, Aout M et al (2011) Evaluation of retinal function and flicker light-induced retinal vascular response in normotensive patients with diabetes without retinopathy. Invest Ophthalmol Vis Sci 52:2861–2867
76. Lott ME, Slocomb JE, Shivkumar V et al (2013) Impaired retinal vasodilator responses in prediabetes and type 2 diabetes. Acta Ophthalmol 91:e462–e469
77. Patel SR, Bellary S, Qin L, Balanos GM, McIntyre D, Gherghel D (2012) Abnormal retinal vascular reactivity in individuals with impaired glucose tolerance: a preliminary study. Invest Ophthalmol Vis Sci 53:5102–5108
78. Sasongko MB, Wong TY, Nguyen TT et al (2012) Serum apolipoproteins are associated with systemic and retinal microvascular function in people with diabetes. Diabetes 61:1785–1792
79. Nguyen TT, Kawasaki R, Kreis AJ et al (2009) Correlation of light-flicker-induced retinal vasodilation and retinal vascular caliber measurements in diabetes. Invest Ophthalmol Vis Sci 50:5609–5613
80. Al-Fiadh AH, Farouque O, Kawasaki R et al (2014) Retinal microvascular structure and function in patients with risk factors of atherosclerosis and coronary artery disease. Atherosclerosis 233:478–484
81. Riva CE, Geiser M, Petrig BL (2010) Ocular blood flow assessment using continuous laser Doppler flowmetry. Acta Ophthalmol 88:622–629
82. Pournaras CJ, Riva CE (2013) Retinal blood flow evaluation. Ophthalmologica 229:61–74
83. Clermont AC, Bursell SE (2007) Retinal blood flow in diabetes. Microcirculation 14:49–61
84. Nagaoka T, Sato E, Takahashi A, Yokota H, Sogawa K, Yoshida A (2010) Impaired retinal circulation in patients with type 2 diabetes mellitus: retinal laser Doppler velocimetry study. Invest Ophthalmol Vis Sci 51:6729–6734
85. Bursell SE, Clermont AC, Kinsley BT, Simonson DC, Aiello LM, Wolpert HA (1996) Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. Invest Ophthalmol Vis Sci 37:886–897
86. Patel V, Rassam S, Newsom R, Wiek J, Kohner E (1992) Retinal blood flow in diabetic retinopathy. BMJ 305:678–683
87. Konno S, Feke GT, Yoshida A, Fujio N, Goger DG, Buzney SM (1996) Retinal blood flow changes in type I diabetes. A long-term follow-up study. Invest Ophthalmol Vis Sci 37:1140–1148
88. Kur J, Newman EA, Chan-Ling T (2012) Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease. Prog Retin Eye Res 31:377–406
89. Hardarson SH (2013) Retinal oximetry. Acta Ophthalmol 91(Thesis 2):1-47
90. Yip W, Siantar R, Perera SA et al (2014) Reliability and determinants of retinal vessel oximetry measurements in healthy eyes. Invest Ophthalmol Vis Sci 55:7104–7110
91. Hammer M, Vilser W, Riemer T et al (2009) Diabetic patients with retinopathy show increased retinal venous oxygen saturation. Graefes Arch Clin Exp Ophthalmol 247:1025–1030
92. Hardarson SH, Stefansson E (2012) Retinal oxygen saturation is altered in diabetic retinopathy. Br J Ophthalmol 96:560–563
93. Jorgensen CM, Hardarson SH, Bek T (2014) The oxygen saturation in retinal vessels from diabetic patients depends on the severity and type of vision-threatening retinopathy. Acta Ophthalmol 92:34–39
94. Khoobehi B, Firn K, Thompson H, Reinoso M, Beach J (2013) Retinal arterial and venous oxygen saturation is altered in diabetic patients. Invest Ophthalmol Vis Sci 54:7103–7106
95. Pournaras CJ, Rungger-Brandle E, Riva CE, Hardarson SH, Stefansson E (2008) Regulation of retinal blood flow in health and disease. Prog Retin Eye Res 27:284–330
96. Hammer M, Heller T, Jentsch S et al (2012) Retinal vessel oxygen saturation under flicker light stimulation in patients with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 53:4063–4068
97. Pratley RE (2013) The early treatment of type 2 diabetes. Am J Med 126:S2–S9
98. Wong TY (2011) Retinal vessel diameter as a clinical predictor of diabetic retinopathy progression: time to take out the measuring tape. Arch Ophthalmol 129:95–96
99. Klein R, Myers CE, Lee KE, Gangnon R, Klein BE (2012) Changes in retinal vessel diameter and incidence and progression of diabetic retinopathy. Arch Ophthalmol 130:749–755
100. Cheung N, Wong TY (2012) Predicting risk of diabetic retinopathy from retinal vessel analysis: personalized medicine in transition. Arch Ophthalmol 130:783–784
101. McGeechan K, Liew G, Macaskill P et al (2009) Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis. Am J Epidemiol 170:1323–1332
102. Cheung CY, Tay WT, Ikram MK et al (2013) Retinal microvascular changes and risk of stroke: the Singapore Malay Eye Study. Stroke 44:2402–2408
103. Lundberg K, Kawasaki R, Sjolie AK, Wong TY, Grauslund J (2013) Localized changes in retinal vessel caliber after focal/grid laser treatment in patients with diabetic macular edema: a measure of treatment response? Retina 33:2089–2095
104. Wickremasinghe SS, Rogers SL, Gillies MC, Zhu M, Wong TY (2008) Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema. Invest Ophthalmol Vis Sci 49:4707–4711
105. Hughes AD, Stanton AV, Jabbar AS, Chapman N, Martinez-Perez ME, McG Thom SA (2008) Effect of antihypertensive treatment on retinal microvascular changes in hypertension. J Hypertens 26:1703–1707
106. Dahlof B, Stenkula S, Hansson L (1992) Hypertensive retinal vascular changes: relationship to left ventricular hypertrophy and arteriolar changes before and after treatment. Blood Press 1:35–44
107. Thom S, Stettler C, Stanton A et al (2009) Differential effects of antihypertensive treatment on the retinal microcirculation: an Anglo-Scandinavian cardiac outcomes trial substudy. Hypertension 54:405–408
108. Aiello LP, Edwards AR, Beck RW et al (2010) Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema. Ophthalmology 117:946–953
109. Regnier S, Malcolm W, Allen F, Wright J, Bezlyak V (2014) Efficacy of anti-VEGF and laser photocoagulation in the treatment of visual impairment due to diabetic macular edema: a systematic review and network meta-analysis. PLoS One 9:e102309
110. Wickremasinghe SS, Busija L, Guymer RH, Wong TY, Qureshi S (2012) Retinal venular caliber predicts visual outcome after intravitreal ranibizumab injection treatments for neovascular AMD. Invest Ophthalmol Vis Sci 53:37–41
111. Lombardo M, Serrao S, Devaney N, Parravano M, Lombardo G (2013) Adaptive optics technology for high-resolution retinal imaging. Sensors (Basel) 13:334–366
112. Koch E, Rosenbaum D, Brolly A et al (2014) Morphometric analysis of small arteries in the human retina using adaptive optics imaging: relationship with blood pressure and focal vascular changes. J Hypertens 32:890–898
113. Jia Y, Bailey ST, Wilson DJ et al (2014) Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. Ophthalmology 121:1435–1444
114. Leitgeb RA, Werkmeister RM, Blatter C, Schmetterer L (2014) Doppler optical coherence tomography. Prog Retin Eye Res 41:26–43
115. Harazny JM, Raff U, Welzenbach J et al (2011) New software analyses increase the reliability of measurements of retinal arterioles morphology by scanning laser Doppler flowmetry in humans. J Hypertens 29:777–782
116. Muraoka Y, Tsujikawa A, Kumagai K et al (2013) Age- and hypertension-dependent changes in retinal vessel diameter and wall thickness: an optical coherence tomography study. Am J Ophthalmol 156:706–714
117. Heitmar R, Blann AD, Cubbidge RP, Lip GY, Gherghel D (2010) Continuous retinal vessel diameter measurements: the future in retinal vessel assessment? Invest Ophthalmol Vis Sci 51:5833–5839